Back
Speaker illustration

Doctor Johannes Wikstrom

(Sweden)

Presentations

Combination therapy with GalNAc-siRNA drugs targeting both PCSK9 and APOC3 resulted in enhanced lipid lowering in mice

Event: ESC Congress 2024

Topic: Drug therapy

Session: Lipids as cardiovascular risk factors and treatment options

Access
Like
Thumbnail

Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats

Event: ESC Congress 2023

Topic: Angiotensin-Renin-Bradykinin System

Session: Clinical pharmacology

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources